Literature DB >> 8948544

Maternal medications and environmental exposures as risk factors for gastroschisis.

C P Torfs1, E A Katz, T F Bateson, P K Lam, C J Curry.   

Abstract

In a case-control study of gastroschisis, we evaluated the risks associated with mother's first-trimester use of medications and with hobby or occupational exposures for 110 cases and 220 controls without a birth defect. Mothers of cases and controls were age-matched. For hobby or occupational exposures, we found significantly elevated risks for high levels of solvents (odds ratio (OR) = 3.8; 95% confidence interval (CI) = 1.6-9.2) and for colorants (OR = 2.3; 95% CI = 1.3-4.0). For medications, we found significantly elevated risks for two strong cyclooxygenase inhibitors, aspirin (OR = 4.7; 95% CI = 1.2-18.1) and ibuprofen (OR = 4.0; 95% CI = 1.0-16.0), but not for acetaminophen, a weak cyclooxygenase inhibitor. Periconceptional exposure to X rays was also associated with gastroschisis (OR = 2.5; 95% CI = 1.2-5.5), but exposure to antibiotics, antinauseants, sulfonamides, or oral contraceptives was not. We also found elevated risks for two decongestants, pseudoephedrine (OR = 2.1; 95% CI = 0.8-5.5) and phenylpropanolamine (OR = 10.0; 95% CI = 1.2-85.6). For the group of all decongestants, including also oxymetazoline and ephedrine, the risk was significantly elevated (OR = 2.4; 95% CI = 1.0-5.4). Controlling in multivariate analyses for several demographic and pregnancy variables associated with gastroschisis in a previous analysis [Torfs et al. (1994) Teratology 50: 44-53] did not substantially change the level or direction of the associations. Most of these associations are for vasoactive substances, which supports a vascular hypothesis for the pathogenesis of gastroschisis.

Entities:  

Mesh:

Year:  1996        PMID: 8948544     DOI: 10.1002/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  39 in total

1.  [Medication therapy during pregnancy].

Authors:  S Gronau; A Neumann
Journal:  HNO       Date:  2012-07       Impact factor: 1.284

Review 2.  Teratogens inducing congenital abdominal wall defects in animal models.

Authors:  Dennis R Van Dorp; John M Malleis; Brian P Sullivan; Michael D Klein
Journal:  Pediatr Surg Int       Date:  2009-09-16       Impact factor: 1.827

3.  Trends in incidence and outcomes of gastroschisis in the United States: analysis of the national inpatient sample 2010-2014.

Authors:  Parth Bhatt; Anusha Lekshminarayanan; Keyur Donda; Fredrick Dapaah-Siakwan; Badal Thakkar; Sumesh Parat; Shilpi Chabra; Zeenia Billimoria
Journal:  Pediatr Surg Int       Date:  2018-07-28       Impact factor: 1.827

4.  Epidemiology and risk factors of amniotic band syndrome, or ADAM sequence.

Authors:  Pietro Cignini; Claudio Giorlandino; Francesco Padula; Nella Dugo; Ester Valentina Cafà; Anna Spata
Journal:  J Prenat Med       Date:  2012-10

Review 5.  Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review.

Authors:  Cameron Gilbert; Paolo Mazzotta; Ronen Loebstein; Gideon Koren
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring.

Authors:  Martha M Werler; Samantha E Parker; Klaus Hedman; Mika Gissler; Annukka Ritvanen; Heljä-Marja Surcel
Journal:  Am J Epidemiol       Date:  2016-11-17       Impact factor: 4.897

Review 7.  Anticoagulant therapy and pregnancy.

Authors:  Aiko Makino; Mayumi Sugiura-Ogasawara
Journal:  Reprod Med Biol       Date:  2008-02-01

Review 8.  Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation.

Authors:  Gary A Incaudo
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

9.  A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England.

Authors:  D N Bateman; P R McElhatton; D Dickinson; C Wren; J N S Matthews; M O'Keeffe; S H L Thomas
Journal:  Eur J Clin Pharmacol       Date:  2004-09-23       Impact factor: 2.953

10.  Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis?

Authors:  Martha M Werler; Allen A Mitchell; Cynthia A Moore; Margaret A Honein
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.